Universal Health set October 26 results date. Universal Health stock gains 1.61 percent.

Published on 10/08/2026 at 13:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter 2026 adjusted EPS was USD 5.98 versus USD 5.66 consensus. Universal Health stock costs EUR 157.50 on October 8, 2026, versus EUR 155.00.

Extreme Nahaufnahme der Fasertextur von sterilem blauem Verbandsmaterial — Makroaufnahme von sterilem Verbandsmaterial zeigt Universal Health, Aktie ISIN US9139031002, feine Fasertextur blauer Gaze, Illustration mit AI erstellt.

Universal Health Services (ISIN US9139031002) was trading at EUR 157.50 at Lang and Schwarz on October 8, 2026, up 1.61 percent versus the previous close. The company had announced on October 5 that it would publish third-quarter 2026 results after the market close on October 26, 2026, according to StockTitan.

Three dates shape the setup

On July 27, 2026, Universal Health Services reported adjusted earnings per share of USD 5.98 for the second quarter, above the USD 5.66 consensus estimate, according to Zacks. On September 18, 2026, Leerink Partners raised its price target from USD 198.00 to USD 205.00 and maintained an Outperform rating, as reported by MarketBeat. On October 5, 2026, Universal Health Services announced its third-quarter reporting date and October 27 conference call, according to StockTitan.

What do the October dates add?

The October 26 release will update a business that generated USD 4.64 billion of revenue in the second quarter of 2026, up 8.30 percent from the same quarter a year earlier, according to MarketBeat. The same report showed adjusted earnings per share of USD 5.98 against USD 5.35 a year earlier, a comparison that puts the October release against a stronger prior-year earnings base. The companys conference call on October 27 at 9:30 a.m. Eastern Time gives analysts a second date for management commentary.

Stock remains below its yearly high

Universal Health Services had a market capitalization of USD 10.6 billion as of October 7, 2026, while its primary-market 52-week range was USD 140.08 to USD 246.33. The current euro quote therefore offers a live Germany-facing reference, while the NYSE range remains a separate US-dollar measure and is not combined with it.

At Lang and Schwarz, the stock was trading at EUR 157.50 on October 8, 2026 at 1:42 p.m. CEST, plus 1.61 percent versus the prior close of EUR 155.00. The further course of trading is shown by the continuously updated real-time quote of Universal Health stock.